Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus
about
Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderlyAntihyperglycaemic treatment patterns, observed glycaemic control and determinants of treatment change among patients with type 2 diabetes in the United Kingdom primary care: a retrospective cohort studyPatient tolerance and acceptance of colesevelam hydrochloride: focus on type-2 diabetes mellitus.Economic impact of combining metformin with dipeptidyl peptidase-4 inhibitors in diabetic patients with renal impairment in spanish patients.Durability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR).Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC StudyPersistence with statin therapy in Hungary.A review of clinical efficacy and safety of canagliflozin 300 mg in the management of patients with type 2 diabetes mellitus.Impact of Canagliflozin Treatment on Health-Related Quality of Life among People with Type 2 Diabetes Mellitus: A Pooled Analysis of Patient-Reported Outcomes from Randomized Controlled Trials.A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study.Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study
P2860
Q33800171-11775D25-4755-412E-A5D5-A5B1A8EFCD7EQ34165512-A3B72B97-BB76-4817-8696-B712A636F009Q34976294-68700238-D845-4051-B29E-A9E9F753AB3BQ35126858-330A40A6-70FF-4630-92D6-5E782465BEABQ35203980-2FE3F1AF-DF17-43D7-9ED6-BB509BAEB5DCQ35661969-A6178498-8F3C-436D-9316-09342442FF80Q36984006-478396BF-908B-4B12-8CD9-DFD906CE87E2Q37588842-3713D3B8-54CF-4D72-9242-603AF50C2B77Q47192734-DBBF9504-E56E-4FA2-B041-7EFDC2DF06A8Q47557571-9F25244D-6A24-4C6D-8BCD-1B6F11D4B1EEQ58767469-42E240BC-FE64-454E-ACC1-3B3117DE56FB
P2860
Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Persistence of initial oral an ...... with type 2 diabetes mellitus
@ast
Persistence of initial oral an ...... with type 2 diabetes mellitus
@en
type
label
Persistence of initial oral an ...... with type 2 diabetes mellitus
@ast
Persistence of initial oral an ...... with type 2 diabetes mellitus
@en
prefLabel
Persistence of initial oral an ...... with type 2 diabetes mellitus
@ast
Persistence of initial oral an ...... with type 2 diabetes mellitus
@en
P2093
P2860
P356
P1476
Persistence of initial oral an ...... with type 2 diabetes mellitus
@en
P2093
Béla Merkely
György Jermendy
György Paragh
György Rokszin
István Karádi
István Wittmann
Lajos Katona
László Nagy
Zoltán Kiss
Zsolt Abonyi-Tóth
P2860
P304
P356
10.12659/MSM.882459
P577
2012-02-01T00:00:00Z